Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -10.8% | +5.9% | 2 / 3 | +23.5% | -2.15 pp | -2.90 pp | +23.9% | 0.00 | 5.29 | 628 | +23,5% | 50,0 | −9,5% | 5.29 | 8.01 | −34,0% |
| Pts | 0 | 0 | 8 | 12 | 4 | 0 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 28.600 (close price on 2026-10-19)EPS (TTM): 5.409
Financial charts
1.Revenue & growth
VND bn628Q2/26
1.Revenue & growth
VND bn628Q2/26
2.Profit & growth
VND bn48,9Q2/26
3.Profit mix (Penman)
VND bn201Q2/26
4.Margins & cost structure
%12.9%Q2/26
5.Returns & cash cycle
% · days32.7%Q2/26
6.Earnings quality & cash
VND bn271Q2/26
7.Asset structure
VND bn1.344Q2/26
8.Funding & debt health
VND bn · times1.344Q2/26
9.Revenue backlog
VND bn2,60Q2/26
10.Valuation
times · %5,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.621Q2/26
Adjusted EPS growth, latest quarter
-10.8%
Average adjusted EPS growth, 3 quarters
5.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26